233 related articles for article (PubMed ID: 21322288)
1. A qualitative evaluation of strategies to increase colorectal cancer screening uptake.
Tinmouth J; Ritvo P; McGregor SE; Claus D; Pasut G; Myers RE; Guglietti C; Paszat LF; Hilsden RJ; Rabeneck L
Can Fam Physician; 2011 Jan; 57(1):e7-15. PubMed ID: 21322288
[TBL] [Abstract][Full Text] [Related]
2. ColonCancerCheck Primary Care Invitation Pilot project: family physician perceptions.
Tinmouth J; Ritvo P; McGregor SE; Guglietti C; Green J; Claus D; Levitt C; Paszat LF; Rabeneck L
Can Fam Physician; 2012 Oct; 58(10):e570-7. PubMed ID: 23064936
[TBL] [Abstract][Full Text] [Related]
3. ColonCancerCheck primary care invitation pilot project: patient perceptions.
Tinmouth J; Ritvo P; McGregor SE; Patel J; Guglietti C; Levitt CA; Paszat LF; Rabeneck L
Can Fam Physician; 2013 Dec; 59(12):e541-9. PubMed ID: 24336559
[TBL] [Abstract][Full Text] [Related]
4. Using physician-linked mailed invitations in an organised colorectal cancer screening programme: effectiveness and factors associated with response.
Tinmouth J; Baxter NN; Paszat LF; Rabeneck L; Sutradhar R; Yun L
BMJ Open; 2014 Mar; 4(3):e004494. PubMed ID: 24622950
[TBL] [Abstract][Full Text] [Related]
5. Comparison of mailed invitation strategies to improve fecal occult blood test participation in men: protocol for a randomized controlled trial.
Duncan A; Zajac I; Flight I; Stewart BJ; Wilson C; Turnbull D
Trials; 2013 Jul; 14():239. PubMed ID: 23902589
[TBL] [Abstract][Full Text] [Related]
6. Increasing participation in colorectal cancer screening: results from a cluster randomized trial of directly mailed gFOBT kits to previous nonresponders.
Tinmouth J; Patel J; Austin PC; Baxter NN; Brouwers MC; Earle C; Levitt C; Lu Y; Mackinnon M; Paszat L; Rabeneck L
Int J Cancer; 2015 Mar; 136(6):E697-703. PubMed ID: 25195923
[TBL] [Abstract][Full Text] [Related]
7. Fecal occult blood test screening uptake among immigrants from Muslim majority countries: A retrospective cohort study in Ontario, Canada.
Vahabi M; Lofters A; Wong JP; Ellison L; Graves E; Damba C; Glazier RH
Cancer Med; 2019 Nov; 8(16):7108-7122. PubMed ID: 31568705
[TBL] [Abstract][Full Text] [Related]
8. Using population data to reduce disparities in colorectal cancer screening, Arkansas, 2006.
Greene P; Mehta P; Yeary KH; Bursac Z; Zhang J; Goldsmith G; Henry-Tillman R
Prev Chronic Dis; 2012; 9():E138. PubMed ID: 22898236
[TBL] [Abstract][Full Text] [Related]
9. Two randomized controlled trials for colorectal cancer screening invitations developed using a behavioral science approach.
Tinmouth J; Llovet D; Sutradhar R; Tsiplova K; Roushani J; Lee A; Hader J; Rabeneck L; Paszat L
Prev Med; 2022 Feb; 155():106918. PubMed ID: 34953810
[TBL] [Abstract][Full Text] [Related]
10. Gender differences in attitudes impeding colorectal cancer screening.
Ritvo P; Myers RE; Paszat L; Serenity M; Perez DF; Rabeneck L
BMC Public Health; 2013 May; 13():500. PubMed ID: 23706029
[TBL] [Abstract][Full Text] [Related]
11. Equity and practice issues in colorectal cancer screening: Mixed-methods study.
Buchman S; Rozmovits L; Glazier RH
Can Fam Physician; 2016 Apr; 62(4):e186-93. PubMed ID: 27618142
[TBL] [Abstract][Full Text] [Related]
12. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
Van Roosbroeck S; Hoeck S; Van Hal G
Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
[TBL] [Abstract][Full Text] [Related]
13. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.
Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J
World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer screening among African American church members: a qualitative and quantitative study of patient-provider communication.
Katz ML; James AS; Pignone MP; Hudson MA; Jackson E; Oates V; Campbell MK
BMC Public Health; 2004 Dec; 4():62. PubMed ID: 15601463
[TBL] [Abstract][Full Text] [Related]
15. "Finding the Right FIT": Rural Patient Preferences for Fecal Immunochemical Test (FIT) Characteristics.
Pham R; Cross S; Fernandez B; Corson K; Dillon K; Yackley C; Davis MM
J Am Board Fam Med; 2017; 30(5):632-644. PubMed ID: 28923816
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of Colon Cancer Screening by Fecal Immunochemical Test in Iran.
Salimzadeh H; Bishehsari F; Sauvaget C; Amani M; Hamzehloo G; Nikfarjam A; Merat S; Delavari A; Malekzadeh R
Arch Iran Med; 2017 Dec; 20(12):726-733. PubMed ID: 29664311
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
[TBL] [Abstract][Full Text] [Related]
18. Impact on immigrant screening adherence with introduction of a population-based colon screening program in Ontario, Canada.
Moustaqim-Barrette A; Spinelli JJ; Kazanjian A; Dummer TJB
Cancer Med; 2019 Apr; 8(4):1826-1834. PubMed ID: 30791219
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
[TBL] [Abstract][Full Text] [Related]
20. Psychosocial consequences of receiving false-positive colorectal cancer screening results: a qualitative study.
Toft EL; Kaae SE; Malmqvist J; Brodersen J
Scand J Prim Health Care; 2019 Jun; 37(2):145-154. PubMed ID: 31079520
[No Abstract] [Full Text] [Related]
[Next] [New Search]
